Posts

Smart Cancer Resources & Research Guide 2026: A Patient-First Map of Diagnosis, Biomarkers, Treatment, Immunotherapy, Resistance & Integrative Oncology

Image
OneDayMD Cancer Resource Library · Network Index · Published September 17, 2026 · Last reviewed and updated November 2026 (v2.1) Cancer information is no longer confined to a single textbook, treatment guideline, or hospital website — and cancer guides should not be limited to oncologists. Modern oncology now spans pathology, staging, molecular biomarkers, precision medicine, prevention, surgery, radiation, chemotherapy, targeted therapy, immunotherapy, cellular therapy, cancer metabolism, treatment resistance, supportive care, and clinical research. This OneDayMD guide brings those subjects together in one navigable resource. Rather than hundreds of disconnected articles, it offers a pathway through the evidence and links directly to deeper OneDayMD, SmartCancer, and Cancer Advisor resources. Quick Answer This page is a map, not a single treatment guide — it connects the OneDayMD network's cancer content by the question you're actually asking. Newly diagnosed and ...

How Precision Medicine & Genomics Are Transforming Cancer Care and Prevention (2026)

Image
The Shift to Personalized Cancer Care Precision medicine, powered by advances in genomics , is revolutionizing how cancer is diagnosed, treated, and even prevented. Unlike the traditional “one-size-fits-all” approach, precision medicine tailors prevention and treatment strategies to each person’s unique genetic makeup, environment, and lifestyle. This shift is leading to more effective therapies, fewer side effects, and earlier interventions ( 1 ,  2 ,  3 ). Key Innovations Driving Change Comprehensive Tumor Profiling: Oncologists now routinely order detailed genetic analyses of tumors, identifying specific mutations that drive cancer growth. This allows for highly targeted therapies that are more likely to be effective for each individual patient ( 1 ,  4 ,  2 ). Targeted Therapies:  Drugs are developed to target specific genetic mutations or proteins found in cancer cells. For example, HER2-targeted therapies (like trastuzumab and tucatinib) have transformed b...

Archive

Show more